'Do not buy this product' Dr Amir Khan weight loss drug warning message

The NHS GP is urging people to avoid the product after he received messages about it from followers and family members

Weight-loss medicines linked to 21% lower fracture risk in type 2 diabetes patients, a new study found, challenging assumptions that rapid weight loss inevitably raises fracture risk.

Pancreatitis — how great is the risk of weight-loss medication?  The Times

CEO Brian Moynihan says GLP-1 medications now account for roughly 13% of the bank's total annual healthcare spending

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.

Retatrutide — also known as "reta" — has been shown to produce dramatically greater weight loss than Ozempic and Mounjaro.

Eli Lilly’s chief executive David Ricks told investors that it was ‘building for the future’

International research suggests losing weight may help people get a job - and their New Zealand counterparts say it can't be ruled out here, either.

Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safet

A breast cancer surgeon explains how GLP-1 drugs like Ozempic and Wegovy may lower cancer recurrence risk by reducing BMI, estrogen and inflammation.

Jaime says TikTok taught her how to buy and inject black market peptides. Months later, she had lost 17kg.

"Employers are dropping coverage for GLP-1 drugs like Wegovy and Zepbound in greater numbers, nudging more patients to direct-to-consumer prescriptions."